Skip to main content
. 2021 Oct 3;5(5):zrab077. doi: 10.1093/bjsopen/zrab077

Table 4.

Histopathological findings and operative outcomes of patients with hepatocellular carcinoma with or without acute kidney injury

AKI No AKI P
(n = 58) (n = 502)
Tumour size (cm)* 5.9 (4.0) 5.0 (3.7) 0.068‡
No. of tumours
 1 33 (56.9) 384 (76.5) 0.001
 2 6 (10.3) 43 (8.6) 0.650
 3 4 (6.9) 11 (2.2) 0.059
 ≥ 4 15 (25.9) 64 (12.7) 0.007
Satellite lesion 24 (41.4) 98 (19.5) < 0.001
Vascular invasion 22 (37.9) 174 (34.7) 0.621
Differentiation
 Well 8 (14.3) 58 (11.8) 0.617
 Moderate 43 (76.8) 386 (78.6) 0.639
 Poor 5 (8.9) 47 (9.6) 0.853
AJCC stage
 I 23 (39.7) 278 (55.4) 0.023
 II 16 (27.6) 131 (26.1) 0.807
 III 16 (27.6) 91 (18.1) 0.083
 IV 3 (5.2) 2 (0.4) 0.009
Resection margin (cm)* 1.34(1.09) 1.42 (1.16) 0.627‡
Clear margin 58 (100) 495 (98.6) 1.000
Child-Pugh grade 0.418
 A 55 (94.8) 487 (97.0)
 B 3 (5.2) 15 (3.0)
Cirrhosis 32 (55.2) 271 (54.0) 0.863
Ruptured HCC 9 (10.3) 30 (6.0) 0.250
90-day mortality 6 (10.3) 5 (1.0) 0.003
Postoperative complications 36 (62.1) 122 (24.3) < 0.001
Clavien–Dindo grade of complication
 I 2 (3.4) 42 (8.4) 0.299
 II 13 (22.4) 41 (8.2) < 0.001
 III 12 (20.7) 36 (7.2) 0.002
 IV 4 (6.9) 1 (0.2) < 0.001
 V 5 (8.6) 2 (0.4) < 0.001
PHLF 5 (8.6) 5 (1.0) 0.002
Duration of postoperative hospital stay (days)* 13.3 (7.7) 8.2 (5.5) < 0.001‡

Values in parentheses are percentages unless indicated otherwise; *values are mean(s.d.). AKI, acute kidney injury; HCC, hepatocellular carcinoma; PHLF, posthepatectomy liver failure. †χ2 or Fisher’s exact test, except ‡Student’s t test.